Version history

{
  "session_id": "sess_SDA-2026-04-10-gap-debate-20260410-075007-232fbf62_task_9aae8fc5",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "## Critical Evaluation of dilncRNA Structural Therapeutic Hypotheses\n\n---\n\n### Hypothesis 1: MALAT1 Triple Helix (Confidence 0.78 → Revised: 0.45)\n\n**Weak Links:**\n- **Nomenclature confusion**: \"Three-way junction\" ≠ \"triple helix.\" Triple helix (triplex) structures involve Hoogsteen-bonded third strands invading duplex regions. The MALAT1 A-rich motif forms a three-way junction (a stem-loop with internal loops), not a triplex. Mislabeling the target structure undermines mechanism clarity.\n- **Overstated conservation**: Brown et al. (2014) demonstrated conservation in mammals, but Liu et al. (2017) explicitly noted sequence divergence in distal regions. Conservation across vertebrates (fish, amphibians) is untested.\n- **Mechanistic gap**: \"Destabilize ribonucleoprotein complex\" assumes triple helix disruption is rate-limiting for speckle localization, but PARP inhibitors (PMID: 28581500) and other protein interactors may compensate.\n\n**Counter-Evidence:**\n- Liu et al. show that while the triple helix is structured, compensatory mutations can restore function—suggesting functional flexibility rather than absolute dependence on the specific structure.\n- ASO degradation studies (e.g., Arun et al., 2016) use transcript-wide knockdown; they do not validate structure-selective targeting.\n\n**Falsifying Experiments:**\n1. Structure-resolution mapping (icSHAPE-seq) across >10 vertebrate species to confirm base-pairing conservation at nucleotide resolution.\n2. Rescue experiments: transcribe a structure-mutated MALAT1 resistant to ASO; test whether speckle localization and splicing are rescued.\n3. **CRITICAL**: Compare triple helix-targeting ASOs (sparing rest of transcript) vs. full-transcript ASOs in Kras models—if only full knockdown works, the triple helix hypothesis is falsified.\n\n---\n\n### Hypothesis 2: NEAT1 A-Tract Bulges (Confidence 0.71 → Revised: 0.38)\n\n**Weak Links:**\n- **Misrepresented conservation**: Yamazaki et al. (2016) showed human-mouse conservation of *some* NEAT1 regions, but NEAT1 is notoriously poorly conserved overall (avg ~40% identity). The specific A-bulge coordinates (nt 2500-3500) may not align with the reported conserved regions.\n- **Contradictory mechanism**: If ASOs target bulges \"without invading base-paired stems,\" how do they achieve therapeutic effect? Paraspeckle disruption via bulge invasion vs. full transcript degradation remains mechanistically unclear.\n- **\"Essential scaffold function\" is undefined**: NEAT1_2 is largely composed of tandem repeats; it's unclear what essential function would remain after bulge targeting.\n\n**Counter-Evidence:**\n- Wang et al. (2019) used DNA oligonucleotides (not ASOs) and crosslinking—these may not reflect ASO accessibility in cells.\n- PARP inhibitor studies (Mariappan et al., 2014) show paraspeckles can form without NEAT1 in some contexts, suggesting redundancy.\n\n**Falsifying Experiments:**\n1. RING-MaP mapping across human, macaque, and mouse NEAT1 to confirm A-bulge geometry is preserved.\n2. Test ASOs targeting conserved bulges vs. adjacent base-paired stems—measure paraspeckle integrity and cell viability separately. If base-pairing disruption (not bulge targeting) causes effects, the hypothesis fails.\n3. **CRITICAL**: DMS-MaPseq in live cells (not in vitro) to confirm bulges are actually unpaired in physiological conditions.\n\n---\n\n### Hypothesis 3: NORAD Terminal Stem-Loop (Confidence 0.69 → Revised:",
  "tokens_used": "856",
  "persona_id": "persona-skeptic"
}